The University of Gothenburg relies on technology from Biognosys

According to a press release, the Schlieren-based biotech company Biognosys has fully equipped the first laboratory in Europe with its P2 plasma enrichment system. The system has been installed at the Proteomics Core Facility at the University of Gothenburg. This is an important step in making Biognosys’ P2 technology more accessible, allowing researchers to conduct more in-depth, high-throughput plasma protein profiling and advance the field of biomarker discovery and translational research.

Unveiled at the American Society for Mass Spectrometry (ASMS) annual conference in the summer of 2024, the proprietary P2 plasma enrichment method uses a novel, single-particle process to achieve unbiased, in-depth, mass spectrometry-based plasma proteomics.

“The P2 platform enables the comprehensive, unbiased discovery of proteins at a cost-effective price for users,” said Carina Sihlbom Wallem, head of the Proteomics Core Facility department at the University of Gothenburg. Her laboratory’s aim is to detect as many proteins as possible. Many disease-relevant biomarkers remain elusive due to their low abundance, so increasing the number of quantifiable circulating proteins is important.

“First, our samples were analyzed at Biognosys, followed by an on-site visit by the project manager,” said the head of the department, explaining the role of the Biognosys implementation team. The same samples were then processed and analyzed at the Swedish university’s facilities under the implementation team’s direction.

Biognosys is a spin-off of the Swiss Federal Institute of Technology in Zurich (ETHZ) based in the Bio-Technopark Schlieren-Zurich.

(Café Europe / translated)